Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader–Willi syndrome

BACKGROUND: Recombinant human growth hormone (rhGH) therapy has shown to improve height and body composition in children with Prader–Willi syndrome (PWS), the evidence of early rhGH treatment on motor and mental development is still accumulating. This study explored the time effect on psychomotor de...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Ruo-Qian, Ying, Yan-Qin, Qiu, Zheng-Qing, Fu, Jun-Fen, Gong, Chun-Xiu, Yang, Yan-Ling, Shi, Wei, Li, Hui, Ma, Ming-Sheng, Wang, Chang-Yan, Liu, Min, Chen, Jia-Jia, Su, Chang, Luo, Xiao-Ping, Luo, Fei-Hong, Lu, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149441/
https://www.ncbi.nlm.nih.gov/pubmed/36564648
http://dx.doi.org/10.1007/s12519-022-00653-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149441/
https://www.ncbi.nlm.nih.gov/pubmed/36564648
http://dx.doi.org/10.1007/s12519-022-00653-y

Ejemplares similares